|| common in complete genomics
|?|| (C;C) (C;T) (T;T) ||28|
] Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD
|Desc||FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4|
] Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study
[PMID 21968013] Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans
[PMID 18794854] MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
[PMID 18794856] MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
[PMID 19177153] Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
[PMID 19764949] Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation.
[PMID 20124285] Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
[PMID 20144966] African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
[PMID 20634883] Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa.
[PMID 22956460] Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.